Also in this playlist...
This transcript is automatically generated
Developments in the fight against cancer you're gonna want to hear this drug makers are announcing early success in clinical trials.
Where drugs are boosting the body's own immune system to fight the deadly disease joining me now with details doctor -- -- them.
-- a logical surgeon and clinical fellow at the Columbia University Medical Center welcome to the show it is terrific to have you here.
I think this is really exciting -- you're using the body's own natural defense to fight this horrible disease.
But this is really exciting -- and in fact the American society can occur -- -- they have that annual meeting in Chicago a and this state who was released as recently as yesterday and they actually published information online in the New England -- -- -- today.
Say very exciting he's looking at -- That is stimulation you mean system helping you mean system to recognize -- -- thousand destroy that this -- -- properties such.
-- up on this cancer cells -- like that a lot I don't.
Everybody out there -- somebody's had cancer maybe they patted themselves.
You say that in some cases here it's a clinical trials it's not available for sale but people could become a part of these clinical trials -- climbing the -- that was published today -- looking at skin cap and says.
That will send it to this costs of trucks and kidney concept and in lung kind of says.
They -- say -- -- it with other comes as some comfort that -- to have a particularly good response like it's getting kind of says kicking cat and says none comes as I'm sure all.
-- the next few months we'll see more -- -- trucks.
Being toxic mold counts -- will be used to look at the experiments that they did this come up I mean how does somebody come up with this idea.
But this is not -- -- even in the eighteen hundreds they would looking at the immune response in connection with bacteria infections may -- Even so many his -- guy if you had bacterial infection that could stimulate your immune response to fight concept of -- -- that was very primitive we've come a long way.
The three such as come after if you -- that was cooking in this initially think that they -- today was published and the unit -- confluence spill over a couple of those details right now so Merck has a drag out that there working with and clinical trials.
They significantly shrunk tumors and 52% of the patients on the highest dose.
And then there's Bristol-Myers Squibb dare tumors shrank an average of -- percent this is Bristol-Myers Squibb.
There it is right there so.
How long does it take something like this to go from clinical trials to market.
Both possible carrying with these trucks we need to get FDA approval to these drugs are available at the -- -- in clinical trials but -- not confront much they have made a -- But this could happen to take secret -- and -- fly this -- act DA label that struck.
As a break street barricade and lost month.
What that means is that these tracks can be expedited pastor got to patients you really need and particularly in -- -- -- this weather is very little alternative available so this is -- I think now a lot of the regular at traditional methods of dealing with cancer turned to kill cancer.
Chemotherapy lots of side effects negative side effects to that.
Do we know anything about the side effects of this technology we Dana about the side effects and achieve quite rightly points is that many if the chemotherapy to trucks that we have.
A very toxic back poisonous to many south in the but they.
The south that stimulate the immune system.
About keeping -- how much -- in -- of side effects thereof some side effects but they tend to be late great things like fever chills fatigue which we see.
With a number of patients but I'm not the -- side effects that we say with a common human therapeutic agents to -- using today you know I.
I don't want to get way out in front of the story because it always takes a long time for these things to be -- -- to actually work.
But you seem hopeful.
I am grateful and the -- that -- -- -- -- have fanning response to seeing these patients with Barry Bonds didn't come says.
-- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- And -- with -- response in these kind of patients with Barry Bonds to -- that I think this type for patients with that's a bad disease has dropped.
Very interest in doctor thanks for joining us if I pitcher to have you on the show thank you.
Filter by section